Security key
40637H109
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 118,494,184
- Total 13F shares
- 120,370,571
- Share change
- -2,044,499
- Total reported value
- $1,760,962,328
- Put/Call ratio
- 59%
- Price per share
- $14.63
- Number of holders
- 186
- Value change
- -$41,616,936
- Number of buys
- 83
- Number of sells
- 87
Report period
Q4 2018
Institutions
186
Top holders
10
HALO full security history
Newer quarter: Q1 2019
Previous quarter: Q3 2018
HALOZYME THERAPEUTICS, INC. SEC filings
HALOZYME THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 40637H109
Recent filing periods:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Third Security, LLC |
13F
|
Company |
12%
|
14,092,771
|
$256,066,000 | — | 30 Sep 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,317,364
|
$241,977,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
11,881,526
|
$215,886,000 | — | 30 Sep 2018 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
7.8%
|
9,228,399
|
$167,680,000 | — | 30 Sep 2018 | |
| BB BIOTECH AG |
13F
|
Company |
7%
|
8,247,860
|
$149,864,000 | — | 30 Sep 2018 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
4,343,168
|
$78,917,000 | — | 30 Sep 2018 | |
| Invesco Ltd. |
13F
|
Company |
3.5%
|
4,179,453
|
$75,941,000 | — | 30 Sep 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3%
|
3,601,604
|
$65,441,000 | — | 30 Sep 2018 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
2.8%
|
3,368,134
|
$61,199,000 | — | 30 Sep 2018 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
2.6%
|
3,135,730
|
$56,976,000 | — | 30 Sep 2018 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
2%
|
2,387,350
|
$43,378,000 | — | 30 Sep 2018 | |
| FMR LLC |
13F
|
Company |
2%
|
2,381,296
|
$43,268,000 | — | 30 Sep 2018 | |
| MSD Partners, L.P. |
13F
|
Company |
1.9%
|
2,245,000
|
$40,792,000 | — | 30 Sep 2018 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.8%
|
2,173,089
|
$39,485,000 | — | 30 Sep 2018 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.8%
|
2,161,872
|
$39,281,000 | — | 30 Sep 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.5%
|
1,821,526
|
$33,097,000 | — | 30 Sep 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
1,694,777
|
$30,794,000 | — | 30 Sep 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,662,376
|
$30,205,000 | — | 30 Sep 2018 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
1,618,760
|
$29,412,000 | — | 30 Sep 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,443,904
|
$26,234,000 | — | 30 Sep 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
1,362,312
|
$24,752,000 | — | 30 Sep 2018 | |
| Jupiter Investment Management Ltd |
13F
|
Company |
1%
|
1,193,727
|
$21,690,000 | — | 30 Sep 2018 | |
| Man Group plc |
13F
|
Company |
0.99%
|
1,178,052
|
$21,405,000 | — | 30 Sep 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.86%
|
1,018,770
|
$18,511,000 | — | 30 Sep 2018 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.84%
|
1,000,000
|
$18,170,000 | — | 30 Sep 2018 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.83%
|
987,867
|
$17,950,000 | — | 30 Sep 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
940,292
|
$17,086,000 | — | 30 Sep 2018 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.75%
|
885,523
|
$16,090,000 | — | 30 Sep 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.68%
|
802,171
|
$14,575,000 | — | 30 Sep 2018 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.65%
|
765,103
|
$13,902,000 | — | 30 Sep 2018 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.62%
|
736,120
|
$13,375,000 | — | 30 Sep 2018 | |
| Elk Creek Partners, LLC |
13F
|
Company |
0.51%
|
601,693
|
$10,933,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
594,639
|
$10,805,000 | — | 30 Sep 2018 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
594,534
|
$10,803,000 | — | 30 Sep 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.5%
|
590,600
|
$10,731,000 | — | 30 Sep 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.45%
|
538,680
|
$9,788,000 | — | 30 Sep 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.43%
|
512,554
|
$9,312,000 | — | 30 Sep 2018 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.42%
|
500,000
|
$9,085,000 | — | 30 Sep 2018 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.42%
|
500,000
|
$9,085,000 | — | 30 Sep 2018 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.4%
|
470,966
|
$8,557,000 | — | 30 Sep 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.38%
|
449,969
|
$8,176,000 | — | 30 Sep 2018 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.38%
|
447,338
|
$8,128,000 | — | 30 Sep 2018 | |
| AXA S.A. |
13F
|
Company |
0.36%
|
428,217
|
$7,781,000 | — | 30 Sep 2018 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.32%
|
376,339
|
$6,838,000 | — | 30 Sep 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.31%
|
370,163
|
$6,725,000 | — | 30 Sep 2018 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.3%
|
350,978
|
$6,377,000 | — | 30 Sep 2018 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.28%
|
332,882
|
$6,048,000 | — | 30 Sep 2018 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.36%
|
428,633
|
$5,969,000 | — | 30 Sep 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.27%
|
322,091
|
$5,852,000 | — | 30 Sep 2018 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.24%
|
288,824
|
$5,248,000 | — | 30 Sep 2018 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2018
As of 31 Dec 2018,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
186 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
120,370,571 shares.
The largest 10 holders included
Third Security, LLC, Vanguard Group Inc, BlackRock Inc., IRIDIAN ASSET MANAGEMENT LLC/CT, BB BIOTECH AG, Invesco Ltd., JPMORGAN CHASE & CO, STATE STREET CORP, PICTET ASSET MANAGEMENT LTD, and Thrivent Financial for Lutherans.
This page lists
186
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
191
Q4 2018 holders
186
Holder diff
-5
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.